Ionis Pharmaceuticals, Inc. (IONS) Operating margin 2016–2025
Ionis Pharmaceuticals, Inc. (IONS) operating margin by fiscal year — reported operating income divided by reported revenue.
-40.4%FY2025 · since FY2016: -5.4% → -40.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -40.4% | +26.9 pp |
| FY2024 | -67.4% | -22.5 pp |
| FY2023 | -44.9% | +24.9 pp |
| FY2022 | -69.8% | -66.1 pp |
| FY2021 | -3.7% | +19.9 pp |
| FY2020 | -23.6% | -56.2 pp |
| FY2019 | 32.6% | +42.8 pp |
| FY2018 | -10.2% | -16.3 pp |
| FY2017 | 6.0% | +11.4 pp |
| FY2016 | -5.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice